Epistra and Shimadzu Corporation Launch Co-Developed Cell Culture Optimization Software 'CellTune'
Epistra Inc. (Headquarters: Minato-ku, Tokyo; CEO: Yosuke Ozawa; hereinafter “Epistra”) announces that the cell culture optimization software “CellTune,” co-developed with Shimadzu Corporation (Headquarters: Kyoto; President: Yasunori Yamamoto; hereinafter “Shimadzu”), is now available for sale from Shimadzu Corporation.
CellTune is software that leverages LC-MS measurement data (144 types of culture supernatant components) and Epistra’s AI optimization technology “Epistra Accelerate” to automatically generate optimal experimental conditions for cell culture.
Key Features
- Statistical Analysis: Enables statistical analysis without deep analytical expertise
- AI Optimization: AI simultaneously identifies optimal conditions across multiple parameters
- Efficient Condition Search: Discovers optimal conditions with fewer experiments
User Support
Epistra provides consulting services including experimental design and statistical data analysis.
About Epistra Accelerate
A Bayesian optimization-based AI platform specialized for condition optimization in life science research.
- Price: 6,000,000 yen (tax excluded)
- Product Page: https://www.an.shimadzu.co.jp/products/life-science-lab-instruments/cell-research/celltune/index.html
Related Articles
Epistra Contributes Article on "AI-Robot-Driven Drug Development" to Pharmacia, Journal of the Pharmaceutical Society of Japan
Epistra CTO Taku Tsuzuki and CEO Yosuke Ozawa contributed an article on AI-robot-driven drug development to Pharmacia, Vol. 62 No. 7, published by the Pharmaceutical Society of Japan.
Cell Culture Optimization Software 'CellTune Ver.2' Launches Globally
Epistra Inc. announces the global launch of 'CellTune Ver.2,' the updated version of the co-developed cell culture optimization software with Shimadzu Corporation, on June 29, 2026. The new version introduces cloud-based subscription delivery and overseas expansion of custom media manufacturing services.
Speaking Engagement: CEO Yosuke Ozawa Presented at the 10th Shonan iPark Regenerative Medicine Seminar
On June 3, 2026, Epistra Inc. CEO Yosuke Ozawa presented at the 10th Shonan iPark Regenerative Medicine Seminar, sharing implementation case studies and future prospects for AI and mathematical optimization in regenerative medicine process development.